WebDisclosure WebDisclosure
Basculer en Français
10964 Companies
239952 Keywords
168724 Articles
129100 Press releases
Headlines Articles Press releases BioXyTran, Inc. Remove
  1. Home
  2. Companies
  3. BioXyTran, Inc.
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 03/02/2026 at 17:45, 6 months 8 days ago

    Bioxytran, Inc. Reports Promising ProLectin-M Study Results

    Clinical Trial COVID-19 Treatment Antiviral Drug BioXyTran ProLectin-M
  • BRIEF

    published on 03/02/2026 at 17:45, 6 months 8 days ago

    Bioxytran, Inc. annonce des résultats prometteurs pour son étude sur la ProLectine-M.

    Essai Clinique Médicament Antiviral BioXyTran Prolectine-M Traitement Du Covid-19
  • PRESS RELEASE

    published on 03/02/2026 at 17:40, 6 months 8 days ago

    Bioxytran, Inc. Reports Positive Phase 1b/2a Clinical Study Results for ProLectin-M, a Broad-Range Antiviral Drug in Mild to Moderate COVID-19

    Bioxytran, Inc. announces positive results from Phase 1b/2a clinical study evaluating oral ProLectin-M in COVID-19 patients, showing earlier viral clearance, clinical improvement, and safety
    COVID-19 Clinical Study Antiviral ProLectin-M Bioxytran Inc.
    Logo of BioXyTran, Inc.
Accesswire
  • Published on 09/10/2026 at 22:25, 18 minutes ago

    Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer

  • Published on 09/10/2026 at 17:46, 4 hours 57 minutes ago

    Groete Access Road Nears Completion

  • Published on 09/10/2026 at 15:20, 7 hours 23 minutes ago

    MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026

  • Published on 09/10/2026 at 15:00, 7 hours 43 minutes ago

    All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)

  • Published on 09/10/2026 at 14:37, 8 hours 6 minutes ago

    Worksport (NASDAQ:WKSP) Invites Shareholders to September 15 CEO Town Hall

View all ACCESSWIRE
EQS Group
  • Published on 09/10/2026 at 22:10, 32 minutes ago

    flatexDEGIRO with changes to the Supervisory Board

  • Published on 09/10/2026 at 22:07, 36 minutes ago

    EQS-Adhoc: flatexDEGIRO SE: Changes to the Supervisory Board

  • Published on 09/10/2026 at 21:25, 1 hour 17 minutes ago

    Ørsted receives final opinion regarding taxation of Walney Extension and Hornsea 1

  • Published on 09/10/2026 at 19:35, 3 hours 7 minutes ago

    EQS-Adhoc: United Internet AG: Group subsidiaries 1&1 AG and IONOS Group SE launch transformation programs

  • Published on 09/10/2026 at 19:21, 3 hours 21 minutes ago

    EQS-Adhoc: IONOS Group SE launches strategic transformation program and strengthens growth foundation

View all EQS
Les Echos
  • Published on 09/10/2026 at 19:30, 3 hours 13 minutes ago

    Availability of the 2026 Interim Financial Report

  • Published on 09/10/2026 at 19:30, 3 hours 13 minutes ago

    Mise à disposition du Rapport Financier Semestriel 2026

  • Published on 09/10/2026 at 18:10, 4 hours 33 minutes ago

    LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 août 2026

  • Published on 09/10/2026 at 17:45, 4 hours 58 minutes ago

    COGRA : RÉSULTATS ANNUELS 2025/26 - Retour à la croissance rentable et structure financière renforcée

  • Published on 09/10/2026 at 17:42, 5 hours ago

    Déclaration d'actions et de droits de vote au 31.08.2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy